Annals of Family Medicine

NOVEMBER 20, 2024

Context: Individuals with complex conditions—those with multiple physical, mental, or behavioral health conditions--require numerous health and social services that are not effectively co-delivered by the current healthcare system. This study also provides the first formal evaluation of the KHH program.

Integrated Care 130

Integrated Care Utilities Illness Healthcare 130

Family Physicians of St. Joseph

SEPTEMBER 25, 2018

Joseph, the family medicine practice is committed to providing exceptional, affordable, patient-centered primary care in SW Michigan without reliance on insurance companies for payment of services. John Proos, with the goal of providing exceptional care to the patients of Berrien County. Joseph, P.C.,

Family Physician 52

Family Physician Family Families Primary Care 52

Physician's Weekly

JUNE 19, 2025

Gowin and his colleagues analyzed data from 1,003 adults between 22 and 36 years of age who had functional magnetic resonance imaging (fMRI), urine toxicology, and cannabis use results collected at one academic site between 2012 and 2015 as part of the Human Connectome Project. The cohort (mean age, 28.7

Community 52

Community Healthcare Diagnosis Medical 52

The Clinical Problem Solvers

APRIL 24, 2025

The episode also explores how digital tools can help youth manage their mental health, while also noting the need for culturally relevant care providers. Disparities in Restraint Practices: Disparities in restraint practices are addressed, particularly the disproportionate use of physical and pharmacologic restraints on Black people.

Mental Health 52

Mental Health Community Hospital Appointment 52

FDA Law Blog

AUGUST 10, 2023

Section 704(a)(4) was added to the FDCA by the Food and Drug Administration Safety and Innovation Action (FDASIA) in July 2012. Despite FDA having the authority to conduct paper inspections since the statutory provision was added to the FDCA by FDASIA in 2012, FDA did not issue a warning letter citing Section 704(a)(4) until January 2021.

Manufacturing 52

Manufacturing Electronics IT Physicals 52

FDA Law Blog

AUGUST 18, 2024

The De Novo process provides a regulatory pathway to classify novel devices for which general controls alone or general and special controls provide reasonable assurance of safety and effectiveness for the intended use. This amendment allowed sponsors with low or moderate risk devices to proactively employ the De Novo process.

Specialization 69

Specialization Hospital Physicals Provider 69

FDA Law Blog

FEBRUARY 29, 2024

A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. That PTE application was submitted to the PTO on July 26, 2012. 6,953,787 [] for [PTE] request under 35 U.S.C. §

Clinic 59

Clinic IT Provider Patient-Centered 59